| 000 | 01726 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516090027.0 | ||
| 264 | 0 | _c20120820 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1553-7374 | ||
| 024 | 7 |
_a10.1371/journal.ppat.1002649 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitchen, Scott G | |
| 245 | 0 | 0 |
_aIn vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells. _h[electronic resource] |
| 260 |
_bPLoS pathogens _c2012 |
||
| 300 |
_ae1002649 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Engineering |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aHIV Core Protein p24 _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xphysiology |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 |
_aVirus Replication _xphysiology |
| 700 | 1 | _aLevin, Bernard R | |
| 700 | 1 | _aBristol, Gregory | |
| 700 | 1 | _aRezek, Valerie | |
| 700 | 1 | _aKim, Sohn | |
| 700 | 1 | _aAguilera-Sandoval, Christian | |
| 700 | 1 | _aBalamurugan, Arumugam | |
| 700 | 1 | _aYang, Otto O | |
| 700 | 1 | _aZack, Jerome A | |
| 773 | 0 |
_tPLoS pathogens _gvol. 8 _gno. 4 _gp. e1002649 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.ppat.1002649 _zAvailable from publisher's website |
| 999 |
_c21711408 _d21711408 |
||